Innovation1 Biotech Stock Buy Hold or Sell Recommendation
| IVBT Stock | USD 0 0.00 0.00% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Innovation1 Biotech is 'Strong Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Innovation1 Biotech given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Innovation1 Biotech, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Innovation1 Biotech Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Innovation1 and provide practical buy, sell, or hold advice based on investors' constraints. Innovation1 Biotech. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Innovation1 |
Execute Innovation1 Biotech Buy or Sell Advice
The Innovation1 recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Innovation1 Biotech. Macroaxis does not own or have any residual interests in Innovation1 Biotech or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Innovation1 Biotech's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Innovation1 Biotech Trading Alerts and Improvement Suggestions
| Innovation1 Biotech generated a negative expected return over the last 90 days | |
| Innovation1 Biotech has some characteristics of a very speculative penny stock | |
| Innovation1 Biotech currently holds 554.4 K in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Innovation1 Biotech has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Innovation1 Biotech until it has trouble settling it off, either with new capital or with free cash flow. So, Innovation1 Biotech's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Innovation1 Biotech sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Innovation1 to invest in growth at high rates of return. When we think about Innovation1 Biotech's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (40.88 M) with loss before overhead, payroll, taxes, and interest of (17 K). | |
| Innovation1 Biotech currently holds about 636.16 K in cash with (3.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 75.0% of Innovation1 Biotech shares are held by company insiders |
Innovation1 Biotech Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Innovation1 Biotech or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Innovation1 Biotech's price will be affected by overall otc stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Innovation1 otc's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.00 | |
Ir | Information ratio | 0.00 |
Innovation1 Biotech Volatility Alert
At this time Innovation1 Biotech exhibits very low volatility. Innovation1 Biotech is a penny stock. Even though Innovation1 Biotech may be a good instrument to invest, many penny otc stocks are speculative instruments that are subject to artificial stock promotions. Please make sure you fully understand upside and downside scenarios of investing in Innovation1 Biotech or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings,sudden promotions and many other similar artificial hype indicators. We also encourage traders to check work history of company executives before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Innovation1 instrument if you perfectly time your entry and exit. However, remember that penny otcs that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Innovation1 Biotech Fundamentals Vs Peers
Comparing Innovation1 Biotech's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Innovation1 Biotech's direct or indirect competition across all of the common fundamentals between Innovation1 Biotech and the related equities. This way, we can detect undervalued stocks with similar characteristics as Innovation1 Biotech or determine the otc stocks which would be an excellent addition to an existing portfolio. Peer analysis of Innovation1 Biotech's fundamental indicators could also be used in its relative valuation, which is a method of valuing Innovation1 Biotech by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Innovation1 Biotech to competition |
| Fundamentals | Innovation1 Biotech | Peer Average |
| Return On Equity | -1.79 | -0.31 |
| Return On Asset | -0.0781 | -0.14 |
| Current Valuation | 1.83 M | 16.62 B |
| Shares Outstanding | 20.02 M | 571.82 M |
| Shares Owned By Insiders | 74.66 % | 10.09 % |
| Price To Earning | 0.01 X | 28.72 X |
| Price To Book | 0.05 X | 9.51 X |
| Gross Profit | (17 K) | 27.38 B |
| EBITDA | (38.33 M) | 3.9 B |
| Net Income | (40.88 M) | 570.98 M |
| Cash And Equivalents | 636.16 K | 2.7 B |
| Cash Per Share | 0.03 X | 5.01 X |
| Total Debt | 554.4 K | 5.32 B |
| Debt To Equity | 0.01 % | 48.70 % |
| Current Ratio | 0.03 X | 2.16 X |
| Book Value Per Share | 0.10 X | 1.93 K |
| Cash Flow From Operations | (3.13 M) | 971.22 M |
| Earnings Per Share | 5.54 X | 3.12 X |
| Number Of Employees | 1 | 18.84 K |
| Beta | 5.08 | -0.15 |
| Market Capitalization | 4.5 M | 19.03 B |
| Total Asset | 43.96 M | 29.47 B |
| Z Score | 4.8 | 8.72 |
| Net Asset | 43.96 M |
Innovation1 Biotech Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Innovation1 . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Innovation1 Biotech Buy or Sell Advice
When is the right time to buy or sell Innovation1 Biotech? Buying financial instruments such as Innovation1 OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Innovation1 Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Transportation Thematic Idea Now
Transportation
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Transportation theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Transportation Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Innovation1 OTC Stock Analysis
When running Innovation1 Biotech's price analysis, check to measure Innovation1 Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovation1 Biotech is operating at the current time. Most of Innovation1 Biotech's value examination focuses on studying past and present price action to predict the probability of Innovation1 Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innovation1 Biotech's price. Additionally, you may evaluate how the addition of Innovation1 Biotech to your portfolios can decrease your overall portfolio volatility.